Peripartum cardiomyopathy (PPCM) is a form of heart failure that develops in the final month of pregnancy or within the first five months after delivery, with no other identifiable cause. The heart muscle weakens and can no longer pump blood efficiently, dropping below 45% pumping capacity (compared to a normal 55% to 70%). Most cases appear right after delivery.
It’s uncommon but serious. In the United States, roughly 1 in 1,000 to 1 in 4,000 deliveries are affected. The condition is about four times more common in Black women than in white women, and Hispanic women have the lowest incidence. Globally, rates are substantially higher in parts of Africa and South Asia.
Symptoms That Mimic Normal Pregnancy
The biggest challenge with PPCM is that its early signs look a lot like late pregnancy. Shortness of breath, swollen ankles, and fatigue are so common in the third trimester that most women (and some clinicians) dismiss them. The difference is one of degree. PPCM causes extreme fatigue, severe shortness of breath that worsens at night or when lying flat, and swelling that extends from the feet up to the knees rather than mild puffiness around the ankles.
Other signs include heart palpitations, a noticeably rapid heartbeat, and chest pain. If shortness of breath is severe enough to wake you from sleep or prevent you from lying flat, that’s a red flag worth raising with your doctor immediately. Mild versions of these symptoms are normal in pregnancy. Extreme versions are not.
What Causes the Heart to Weaken
The exact mechanism isn’t fully understood, but one leading explanation centers on prolactin, the hormone responsible for milk production. In some women, prolactin gets cleaved into a smaller fragment that damages the tiny blood vessels feeding the heart muscle. This fragment disrupts the growth, repair, and remodeling of those blood vessels, essentially starving the heart of its own blood supply and weakening its ability to contract.
Why this happens in some women and not others likely involves a combination of genetic susceptibility and cardiovascular stress. Pregnancy places enormous demands on the heart, increasing blood volume by nearly 50%. For most women, the heart adapts. In PPCM, it doesn’t.
Who Is at Higher Risk
Several factors increase the likelihood of developing PPCM:
- Age over 30. The average age at diagnosis is around 30, and risk rises with maternal age.
- African descent. Black women in the U.S. face a fourfold higher incidence compared to white women.
- Preeclampsia or pregnancy-related high blood pressure. A history of preeclampsia, eclampsia, or postpartum hypertension is one of the strongest associated risk factors.
- Multiple pregnancies. Carrying twins or higher-order multiples increases cardiac demand.
Having none of these risk factors doesn’t rule it out. PPCM can occur in otherwise healthy women with no prior heart problems.
How It’s Diagnosed
Diagnosis relies on an echocardiogram, an ultrasound of the heart that measures how well it pumps. A normal heart ejects 55% to 70% of its blood with each beat. PPCM is diagnosed when that number, called the ejection fraction, drops below 45% during the defined time window (last month of pregnancy through five months postpartum) and no other cause is found. Blood tests and other imaging may be used to rule out other conditions like a blood clot in the lungs or preexisting heart disease.
Timing matters enormously. Data from a study published in the AHA journal Hypertension found that women diagnosed within the first month after delivery recovered at a rate of about 70%, compared to only 54% of women diagnosed later. Early diagnosis also shortened recovery time considerably: a median of 4 months versus 7 months for late diagnosis.
Treatment and Recovery
PPCM is treated with the same core medications used for other forms of heart failure: drugs that reduce fluid overload, lower blood pressure, and ease the workload on the heart. If the condition is caught in an acute crisis, hospitalization may be needed to stabilize fluid levels and support heart function.
For women who are breastfeeding, medication choices require some balancing. Common water pills used to reduce fluid buildup transfer into breast milk at very low levels and are generally considered compatible with breastfeeding. Other heart failure medications carry more caution, with potential effects on the infant including low blood pressure, drowsiness, and poor feeding. Your cardiologist and obstetrician will typically work together to find a medication plan that manages the heart failure while accounting for breastfeeding goals.
One treatment approach specific to PPCM targets the prolactin pathway directly. A medication that blocks prolactin release has been studied in clinical trials, based on the theory that stopping prolactin production prevents the damaging fragment from forming. Early trial data is promising, though this approach requires women to stop breastfeeding since it suppresses milk production entirely.
The good news is that recovery rates are relatively high compared to other forms of cardiomyopathy. Between 61% and 72% of women in recent studies regain normal heart function. Recovery typically takes several months, and women remain on heart failure medications during that time even as they feel better. Some women recover fully within weeks; others take a year or more.
Risk in Future Pregnancies
One of the most consequential questions after a PPCM diagnosis is whether it’s safe to become pregnant again. The honest answer is that subsequent pregnancy carries real risk. Relapse rates in published studies range from about 5% to 30%, and the condition can return even in women whose hearts fully recovered.
The single most important predictor of how a future pregnancy will go is whether heart function has returned to normal before conceiving. Women with persistent heart weakness going into another pregnancy face dramatically higher complications. One meta-analysis found that ongoing reduced heart function before a subsequent pregnancy was associated with a 13-fold increase in mortality risk compared to women who had fully recovered. Preeclampsia is the most common complication in these subsequent pregnancies.
Women whose hearts did recover before becoming pregnant again fared much better, and those who relapsed during a subsequent pregnancy were generally able to recover again. Still, the decision involves careful risk assessment with a cardiologist, ideally one experienced in pregnancy-related heart disease. Heart function monitoring throughout any future pregnancy is essential.
Long-Term Outlook
Women who recover fully from PPCM can return to normal activity and live without ongoing heart failure symptoms. However, “recovered” on an echocardiogram doesn’t always mean the heart is entirely back to its pre-pregnancy state at a cellular level. Some women experience a gradual decline in heart function years later, particularly if they had a very low ejection fraction at diagnosis.
Ongoing follow-up with a cardiologist, even after recovery, helps catch any late changes early. Most women who recover do well long-term, but PPCM is a condition that warrants continued attention rather than a single recovery milestone.